Financials

News Ideas Discussions Technicals Forecast Seasonals

CBIO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Crescent Biopharma, Inc.

Total assets of CBIO for Q2 25 is 157.43 M USD, 2527.31% more than the previous Q1 25. And total liabilities increased by 594.67% in Q2 25 to 18.18 M USD.

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD